Actively Recruiting

Phase Not Applicable
All Genders
NCT07500116

NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks

Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2026-03-30

250

Participants Needed

1

Research Sites

125 weeks

Total Duration

On this page

Sponsors

H

Hospital Universitari Vall d'Hebron Research Institute

Lead Sponsor

V

Vall Hebron Insitut Recerca

Collaborating Sponsor

AI-Summary

What this Trial Is About

In this project, we aim to validate a Home Hospitalization plan for patients with TIA or minor stroke. Our hypothesis is that our Multimodal Home Hospitalization program (NORAHOME) for patients with TIA and minor stroke is safe, reduces the complications associated with conventional hospitalization, and is more efficient than Standard Clinical Practice. To conduct the study, we require the voluntary participation of patients with TIA and minor strokes.

CONDITIONS

Official Title

NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Patients presenting to the Emergency Department with symptoms of TIA (complete recovery of neurological deficits within <24 hours) or minor stroke (NIHSS ≤ 5)

  • Age >18 years.
  • Availability of a smartphone for the patient or caregiver.
  • Family support and/or formal caregiver.
  • Clinical stability during the last 12 hours in the Emergency Department.
  • Signed informed consent by the patient and/or family member or legal representative.
Not Eligible

You will not qualify if you...

  • Severe stenosis or symptomatic arterial occlusion requiring admission for potential reperfusion and/or arterial revascularization treatments.
  • Patients with pre-existing neurological or psychiatric conditions that may interfere with or complicate follow-up and evaluations.
  • Clinical (terminal condition) or social (language barrier) impossibility to complete follow-up assessments.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Vall Hebron University Hospital

Barcelona, Spain, 08035

Actively Recruiting

Loading map...

Research Team

M

Marian Muchada Lopez, MD, PHD

CONTACT

M

Marta Rubiera del Fueyo, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here